Lubris BioPharma Overview
- Year Founded
-
2011

- Status
-
Private
- Employees
-
4

- Latest Deal Type
-
2ndary - Private
- Investors
-
5
Lubris BioPharma General Information
Description
Developer of a human lubricin designed for the treatment of the dry eye. The company offers an endogenous complex glycoprotein that binds to and protects tissue surfaces from friction-induced wear and damage and helps in the treatment of surgical adhesions, xerostomia, pericarditis, and other conditions, enabling doctors to offer improved treatment for dry eye disease.
Contact Information
Website
www.lubris.netCorporate Office
- 85 Nobscot Road
- Weston, MA 02493
- United States
Corporate Office
- 85 Nobscot Road
- Weston, MA 02493
- United States
Lubris BioPharma Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Secondary Transaction - Private | 15-Mar-2017 | Completed | Generating Revenue | |||
5. Later Stage VC | Completed | Generating Revenue | ||||
4. Early Stage VC (Series A) | 01-Jul-2015 | Completed | Generating Revenue | |||
3. Accelerator/Incubator | 22-Sep-2014 | Completed | Pre-Clinical Trials | |||
2. Seed Round | 15-Mar-2013 | $4M | $4M | Completed | Startup | |
1. University Spin-Out | 01-Jan-2011 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Lubris BioPharma Patents
Lubris BioPharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3976085-A4 | Use of prg4 to treat cancer | Inactive | 03-Jun-2019 | ||
EP-3976085-A1 | Use of prg4 to treat cancer | Inactive | 03-Jun-2019 | ||
US-20220332839-A1 | Use of prg4 to treat cancer | Inactive | 03-Jun-2019 | ||
EP-3810181-A1 | Lubricin for use in wound healing | Inactive | 21-Jun-2018 | ||
AU-2019290206-A1 | Lubricin for use in wound healing | Inactive | 21-Jun-2018 | A61K38/39 |
Lubris BioPharma Signals
Lubris BioPharma Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Tarnagulla Ventures | Venture Capital | Minority | ||
CONNECT(San Diego) | Accelerator/Incubator | |||
Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | |||
University of Washington | University | |||
SeedFolio | Venture Capital | Minority |
Lubris BioPharma FAQs
-
When was Lubris BioPharma founded?
Lubris BioPharma was founded in 2011.
-
Where is Lubris BioPharma headquartered?
Lubris BioPharma is headquartered in Weston, MA.
-
What is the size of Lubris BioPharma?
Lubris BioPharma has 4 total employees.
-
What industry is Lubris BioPharma in?
Lubris BioPharma’s primary industry is Biotechnology.
-
Is Lubris BioPharma a private or public company?
Lubris BioPharma is a Private company.
-
What is Lubris BioPharma’s current revenue?
The current revenue for Lubris BioPharma is
. -
How much funding has Lubris BioPharma raised over time?
Lubris BioPharma has raised $4M.
-
Who are Lubris BioPharma’s investors?
Tarnagulla Ventures, CONNECT(San Diego), Johnson & Johnson Innovation - JLABS, University of Washington, and SeedFolio have invested in Lubris BioPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »